1244087

Neurocrine Biosciences Inc — FEI 1000202524

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 18, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Diego, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673021 CFR 314.80(b)Failure to develop written procedures